These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32962618)

  • 1. Nanoscale Drug Delivery Systems for Glaucoma: Experimental and
    Sharma S; Bhatia V
    Curr Top Med Chem; 2021; 21(2):115-125. PubMed ID: 32962618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.
    Sah AK; Suresh PK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):448-459. PubMed ID: 27002850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current nanotechnological strategies for treating glaucoma.
    Goyal G; Garg T; Rath G; Goyal AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(5):365-405. PubMed ID: 25271557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines for the treatment of glaucoma: Current status and future perspectives.
    Zhai Z; Cheng Y; Hong J
    Acta Biomater; 2021 Apr; 125():41-56. PubMed ID: 33601065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma: Current treatment and impact of advanced drug delivery systems.
    Yadav KS; Rajpurohit R; Sharma S
    Life Sci; 2019 Mar; 221():362-376. PubMed ID: 30797820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
    Woodward DF; Wang JW; Coleman RA; Woodrooffe AJ; Clark KL; Stamer WD; Tao G; Fan S; Toris CB
    J Ocul Pharmacol Ther; 2019 Jun; 35(5):265-277. PubMed ID: 31025909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progression of drug delivery system for glaucoma].
    Xu Y; Lyu L
    Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
    Nagai N
    Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of antiglaucoma drugs: ocular vs systemic absorption.
    Urtti A
    J Ocul Pharmacol; 1994; 10(1):349-57. PubMed ID: 8207339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy.
    Luo LJ; Nguyen DD; Lai JY
    Biomaterials; 2020 Jun; 243():119961. PubMed ID: 32171102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of nanomedicine for ocular drug delivery.
    Meng T; Kulkarni V; Simmers R; Brar V; Xu Q
    Drug Discov Today; 2019 Aug; 24(8):1524-1538. PubMed ID: 31102733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-ophthalmology: Applications and considerations.
    Kamaleddin MA
    Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in ocular drug delivery: emphasis on the posterior segment.
    Kang-Mieler JJ; Osswald CR; Mieler WF
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1647-60. PubMed ID: 24975820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
    Andonova VY
    Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.